These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23550023)

  • 1. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
    Park JA; Jun KR; Nam SH; Ghim TT
    Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.
    Kim BK; Hong KT; Kang HJ; An HY; Choi JY; Hong CR; Park KD; Lee DS; Shin HY
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):e336-e337. PubMed ID: 29889803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.
    Ishida F; Ko YH; Kim WS; Suzumiya J; Isobe Y; Oshimi K; Nakamura S; Suzuki R
    Cancer Sci; 2012 Jun; 103(6):1079-83. PubMed ID: 22360679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
    Haji S; Shiratsuchi M; Matsushima T; Takamatsu A; Tsuda M; Tsukamoto Y; Tanaka E; Ohno H; Fujioka E; Ishikawa Y; Imadome KI; Ogawa Y
    Int J Hematol; 2017 Apr; 105(4):540-544. PubMed ID: 27830541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
    Ichikawa S; Fukuhara N; Yamamoto J; Suzuki M; Nakajima S; Okitsu Y; Kohata K; Onishi Y; Ishizawa K; Kameoka J; Harigae H
    Intern Med; 2010; 49(17):1907-10. PubMed ID: 20823655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible Concomitant Aggressive NK Cell Leukemia and EBV-positive T-cell lymphoma; Using the online beta version of WHO-HAEM5 and videoconferencing software to make diagnoses accessible in an emerging economy.
    Dayton VJ; Hoang Thien D; Xinh PT; Arries C; Sang NN; Linh NNN; Lien NP; Dung PC
    Diagn Pathol; 2023 Oct; 18(1):111. PubMed ID: 37803436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?
    Ko YH; Park S; Kim K; Kim SJ; Kim WS
    Acta Haematol; 2008; 120(4):199-206. PubMed ID: 19153474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
    Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
    Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-associated aggressive natural killer cell leukemia.
    Rashidi A; Fisher SI
    Blood; 2016 May; 127(20):2502. PubMed ID: 28092886
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.
    Yamashita Y; Nishikawa A; Iwahashi Y; Fujimoto M; Sasaki I; Mishima H; Kinoshita A; Hemmi H; Kanazawa N; Ohshima K; Imadome KI; Murata SI; Yoshiura KI; Kaisho T; Sonoki T; Tamura S
    Int J Hematol; 2019 Jun; 109(6):744-750. PubMed ID: 30706328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
    Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
    PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult aggressive natural killer cell leukemia.
    Zhang H; Meng Q; Yin W; Xu L; Lie L
    Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.
    Sugimoto KJ; Shimada A; Wakabayashi M; Imai H; Sekiguchi Y; Nakamura N; Sawada T; Ota Y; Takeuchi K; Ito Y; Kimura H; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(1):411-7. PubMed ID: 24427365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
    Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features and treatment of aggressive natural killer cell leukemia: case series and literature review.
    Ni Y; Li L; Wang Y; Sun L
    Turk J Pediatr; 2024 Oct; 66(4):481-489. PubMed ID: 39387420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term survival in aggressive NK cell leukemia.
    Patel AP; Ghatak SB; Patel JA
    Indian Pediatr; 2010 Sep; 47(9):807-8. PubMed ID: 21048272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS; Oon ML; Wang S; Tan SY; Ng SB
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.